Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01145430
Brief Title: Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

First Submitted : June 15, 2010
First Submitted that Met QC Criteria : June 15, 2010
First Posted : June 16, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : December 21, 2017
Last Update Posted : December 22, 2017